Julian Ellis

Julian Ellis

Sheppard Mullin Richter & Hampton LLP

Contact
View Bio
RSS

Latest Posts › Abbreviated New Drug Application (ANDA)

Share:

Federal Circuit Upholds Rifaximin Patent Rulings, Affirms ANDA Approval Restrictions

In Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals, Inc. 2023-1952 (Fed. Cir. April 11, 2024), this case involves appellate review of a district court’s findings regarding patent obviousness and infringement in...more

6/7/2024  /  Abbreviated New Drug Application (ANDA) , Appeals , Food and Drug Administration (FDA) , Hatch-Waxman , Intellectual Property Protection , Patent Infringement , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide